Literature DB >> 12464531

Cerebrovascular responses to pathophysiological insult in diabetic rats.

I P Fouyas1, P A T Kelly, I M Ritchie, G A Lammie, I R Whittle.   

Abstract

Diabetes mellitus is associated with altered cerebrovascular responsiveness and this could contribute to the pathology of stroke in diabetic patients. In these studies, we used a model of haemorrhagic stroke (intrastriatal injection of 50 microl blood) to examine subacute perilesional perfusion and blood-brain barrier (BBB) integrity in spontaneously diabetic rats. Volumes of striatal oligaemia (blood flow < 35 ml 100 g(-1) min(-1)) were significantly increased (>300%) in diabetic rats with intrastriatal blood, compared to either non-diabetic rats with blood or control diabetic rats with striatal injection of silicon oil. However, the increase in BBB permeability was both qualitatively and quantitatively similar in diabetic and control rats. Poorer outcomes following haemorrhagic stroke in diabetic patients may thus result from dysfunctional cerebrovascular control, and particularly decreased dilatatory reserve.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12464531     DOI: 10.1016/s0967-5868(02)00247-3

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Neuroprotective actions of ghrelin and growth hormone secretagogues.

Authors:  Laura M Frago; Eva Baquedano; Jesús Argente; Julie A Chowen
Journal:  Front Mol Neurosci       Date:  2011-09-28       Impact factor: 5.639

2.  Detection of chronic brain damage by diffusion-weighted imaging with multiple b values in patients with type 2 diabetes.

Authors:  Tieli Liu; Yunpeng Han; Lemei Tang; Jianlin Wu; Yanwei Miao; Bingbing Gao; Jin Shang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 3.  The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.

Authors:  Youhua Xu; Hua Zhou; Quan Zhu
Journal:  Front Aging Neurosci       Date:  2017-04-27       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.